Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 296533

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : September | Volume : 16 | Issue : 9 | Page : CC09 - CC12 Full Version

Serum Levels of Inflammatory Markers in Newly Diagnosed Hypothyroid Patients Before and After Levothyroxine Therapy


Published: September 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/56898.16940
Shilpi Goyal, Abhinav Dixit, Neelam Vaney, SV Madhu

1. Assistant Professor, Department of Physiology, University College of Medical Sciences, New Delhi, India. 2. Professor and Head, Department of Physiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. 3. Director, Professor and Head, Department of Physiology, University College of Medical Sciences, New Delhi, India. 4. Director and Professor, Department of Endocrinology, University College of Medical Sciences, New Delhi, India.

Correspondence Address :
Dr. Shilpi Goyal,
Assistant Professor, Department of Physiology, University College of Medical Sciences, Dilshad Garden, New Delhi, India.
E-mail: shilpigoyal16@gmail.com

Abstract

Introduction: Cytokines have a great significance in autoimmune thyroid disease. They are produced by thyroid follicular cells and have an indispensable role in T-cell and B-cell growth and differentiation. Tumour necrosis factor-alpha (TNF-α) is a cytokine having numerous immunological and metabolic activities and is an important stimulus for Interleukin-6 (IL-6) production. Interleukins play an important role in immune system function. Their deficiency causes autoimmune diseases or immune deficiency.

Aim: To assess inflammatory markers IL-6 and TNF-α in hypothyroidism before and after attainment of euthyroid state by levothyroxine therapy and to find the correlation between serum levels of TNF-α and hypothyroid state.

Materials and Methods: This quasi-experimental study was conducted at Department of Physiology at University College of Medical Sciences, Delhi, India, from January 2013 to October 2013. Total 30 newly diagnosed hypothyroid patients of the age group 18-45 years formed case group and 30 age and sex-matched subjects formed the control group, were recruited for the study. The patients were given levothyroxine replacement therapy for three months. The inflammatory biomarkers level was evaluated using solid-phase sandwich Enzyme Linked Immunosorbent Assay (ELISA), using kits from Diaclone. Paired and Unpaired t-tests respectively were used for hypothyroid patients in pre-post state and between two groups at baseline. Serum Thyroid Stimulating Hormone (TSH) levels of hypothyroid patients were correlated with serum levels of inflammatory markers using Pearson’s correlation test.

Results: There was no statistical difference in age, sex, body mass index and lipid profile in the two groups. Hypothyroidism subjects achieved euthyroidism in three months months after obtaining levothyroxine therapy with the mean TSH levels 26.43±10.244 vs 3.4863±0.1963, mean free T3 levels 0.2980±.09408 vs 1.93±0.5690 and mean free T4 levels 0.2736±0.0973 vs 1.8986±0.2853 in pre-post states respectively. Serum levels of IL-6 and TNF-α were significantly higher (p-value<0.001) in hypothyroid subjects compared to euthyroid controls. A positive correlation between serum levels of IL-6 (r-value= 0.5778, p-value= 0.0008) and TNF-α (r-value= 0.521, p-value= 0.003) with serum TSH levels were found.

Conclusion: The study reported a significant effect of levothyroxine therapy in restoring serum levels of raised inflammatory markers among hypothyroid patients. A decrease in low-grade chronic inflammation after treatment showed some clinical importance as chronic inflammation is known to be associated with atherosclerosis and cardiac disease.

Keywords

Chronic inflammation, Interleukin 6, Thyroid stimulating hormone, Tumor necrosis factor-α

Thyroid hormones are important in the regulation of innate immune responses (1). Thyroid hormone disturbances do impact the integrity and working of immune cells, which is reflected in host defense status and associated diseases. Immune disturbances are also responsible for the various thyroid dysfunctions, having autoimmune aetiology. Autoimmune thyroiditis is the most common cause of hypothyroidism. Hashimoto’s thyroiditis occurs due to the inflammation caused by autoimmunity. Pieces of evidence have been showing the association of chronic inflammation with cardiovascular events (2),(3). Hashimoto’s thyroiditis (4),(5), has been associated with an increased risk of atherosclerosis and cardiovascular events along with endothelial dysfunction caused by low-grade inflammation. Studies in the past have shown an association of hypothyroidism with inflammatory markers. Some studies have reported raised levels of proinflammatory markers in the hypothyroid state (6),(7),(8) while other have shown reduced levels of inflammatory markers in the hypothyroid state (9). Inflammatory markers have a role in predicting cardiovascular risk (10). Interleukin-6 (IL-6), an inflammatory marker is acting as an inducer for the activity of C-Reactive Protein (CRP) (11). CRP is a known marker for the diagnosis of cardiac risk (12). Most of these studies are cross-sectional (6),(7),(8),(13). Thus, the present interventional study was conducted to see the effect of levothyroxine therapy on the levels of deranged inflammatory markers.

Moreover, the role of increased cytokine levels in severe Coronavirus Disease 2019 (COVID-19) infection with the worst outcomes is well known (14). In the current COVID-19 pandemic, clinicians are concerned about the impact of COVID-19 on pre-existing illnesses or newly developing disease processes. Thyroid disease is also associated with severe COVID-19 infection (15),(16). A recent study reported an association between thyroid dysfunction with clinical severity and poorer prognosis in COVID-19 patients. The authors found significantly higher severe inflammation (IL-6 levels) with low free Triiodothyronine (fT3), levels (17).

Goyal S et al., reported a significant reduction in cognitive skills with hypothyroidism and the role of levothyroxine treatment on the restoration of various cognitive domains by using various paper pencil tests (18) and also by computerised automated stroop task for measuring cognitive inhibition among executive functions (19). They found a positive correlation between cognitive impairments and serum Thyroid Stimulating Hormone (TSH) values.

As we are aware of the adverse effect of inflammatory markers on cardiovascular events (20) and their association in COVID-19 patients along with thyroid dysfunctions (15),(16),(21),(22),(23). The present study was planned on the hypothesis of higher levels of inflammatory biomarkers in hypothyroid patients. This study was to further confirm the available literature and to see the effect of levothyroxine therapy on the raised inflammatory markers in hypothyroid patients who were drug naïve on coming to Outpatient Department (OPD). Most of the earlier studies have been done in subclinical hypothyroid patients (6),(7),(8) and they were cross-sectional. The present study was planned to evaluate the serum levels of inflammatory markers IL-6 and TNF-α, and their correlation with serum TSH in newly diagnosed hypothyroid patients and euthyroid controls, and to compare the same after attainment of euthyroid state.

Material and Methods

This quasi-experimental study was conducted at Department of Physiology at University College of Medical Sciences, Delhi, India, from January 2013 to October 2013 with drug naïve 30 hypothyroid patients. Written informed consent was taken from all the study subjects and the Institutional Ethics Committee clearance was obtained.

Inclusion criteria: Patients of 18-45 years age group without having a previous medical history of any disease like hypertension, diabetes mellitus, cardiovascular risk factor, deranged lipid profile {Low-Density Lipoprotein (LDL) cholesterol<160 mg/dL and triglycerides <180 mg/dL} (7), or any other systemic inflammatory diseases were included in the study.

• Case group (n=30): To see the immediate effect of levothyroxine treatment on inflammatory markers, newly diagnosed hypothyroid patients were taken as study subjects.
• Control group (n=30): Healthy euthyroid subjects with age, sex, Body Mass Index (BMI) and lipid profile matched with the patient group were recruited as controls among the patient’s relatives and staff.

Exclusion criteria: Pregnant women, subjects with BMI≥30 kg/m2, smokers, alcoholics and individuals following any drug regimen were excluded from the study.

Study Procedure

An overnight fasting blood sample was taken. The estimation of serum levels of free T3 (fT3), free T4 (fT4) and TSH of the patients and controls were done by using Radioimmunoassay (RIA) kit from Immunotech Bechmancoulter. Following are the normal hormonal ranges of the laboratory:

• TSH: 0.17-4.0 μIU/mL
• fT4: 0.95-2.23 ng/dL
• fT3: 1.5-5 pg/mL

On centrifuging the blood, obtained serum was stored at -80°C until it was processed for inflammatory markers measurement. Serum IL-6 and TNF-α were detected by solid-phase sandwich Enzyme Linked Immunosorbent Assay (ELISA), using kits from Diaclone. Biochemical markers were assessed in hypothyroid patients at the time of diagnosis and after the attainment of a euthyroid state as suggested by the normalization of thyroid hormones with levothyroxine replacement therapy for three months duration. Controls were assessed only once due to financial constraints. Serum TSH levels of hypothyroid patients were correlated with serum levels of inflammatory markers.

Statistical Analysis

Statistical Package for Social Sciences (SPSS) version 20.0 was used for data analysis. All the baseline parameters were expressed as mean and standard deviation. Biochemical measures were compared at the initial and final level by paired t-test and between cases and controls at baseline by Unpaired t-test. Pearson’s correlation test was used for correlation between serum TSH, IL-6 and TNF-α. A p-value <0.05 was considered significant.

Results

There was no statistical difference in age, sex, BMI and lipid profile in the two groups (Table/Fig 1). Serum TSH was significantly higher (p-value<0.001) 26.43±10.244 vs 3.18±0.855 μIU/mL while serum fT3 0.2980±.09408 vs 2.35±0.585 pg/mL and serum fT4 0.2736±0.0973 vs 1.957±0.2796 ng/dL were significantly lower (p-value<0.001) in hypothyroid patients than controls. All patients were euthyroid after 3 months of levothyroxine replacement therapy. Significant decrease (p-value<0.001) in the TSH level (from 26.43±10.244 to 3.4863±0.1963 μIu/mL) was seen in cases after three months. The fT3 from 0.2980±.09408 to 1.93±0.5690 pg/mL and fT4 from 0.2736±0.0973 to 1.8986±0.2853 ng/dL levels showed significant increase (p-value<0.001) post levothyroxine replacement therapy.

Hypothyroid patients had significantly higher serum IL-6 and TNF-α values than control subjects. Mean serum IL-6 5.53±0.950 vs 4.57±0.734 pg/mL and mean TNF-α levels 15.43±1.568 vs 13.81±1.587 pg/mL were significantly decreased in hypothyroid patients after attaining euthyroidism (Table/Fig 2), (Table/Fig 3). Serum TSH values were positively correlated with their serum IL-6 (r-value= 0.5778, p-value= 0.0008) and TNF α (r-value= 0.521, p-value= 0.003) values in hypothyroid patients (Table/Fig 4), (Table/Fig 5).

Discussion

Present findings have supported the association of hypothyroidism with increased inflammatory markers levels compared to the control group and which can be a reason for cardiovascular risk in hypothyroid patients. In this study, both case and control groups were age, sex, BMI and lipid profile matched and there was no history of any kind of inflammatory disease, proving that the inflammatory findings in the hypothyroid group was not having any pre-existing pathology. Inflammatory markers levels decreased after levothyroxine therapy in drug-naïve newly diagnosed hypothyroid patients showed the role of early diagnosis and hormone replacement therapy in reversing the future risk of cardiovascular disease which can arise due to the prolonged hypothyroid state (6).

Previous studies have shown conflicting results regarding hypothyroid state and deranged inflammatory markers (7),(8),(9). This study reported that serum levels of IL-6 and TNF-α were significantly higher in hypothyroid patients than euthyroid controls. This is in concurrence with Taddei S et al., who reported patients with hypothyroidism, were having low-grade chronic inflammation, which was approved by a significant rise in high sensitive CRP and IL-6 (7). The author suggested the increased risk of atherosclerosis and ischemic heart disease in hypothyroidism may be due to endothelial dysfunction caused by low-grade chronic inflammation. A significantly higher concentration of IL-6 and TNF-α in subclinical hypothyroid patients was supported by Turemen EE et al., (8). Contrary to present findings, in a study done by Kilziltunc A et al., hyperthyroid patients had increased serum levels of the cytokines IL-6 and TNF-α and hypothyroid patients had decreased levels of IL-6 and TNF-α (9). Lakatos P et al., found increased IL-6 levels in hyperthyroid women. However, hypothyroidism did not significantly reduce serum IL-6. Serum IL-6 normalised on remission of the disease indicated that it was related to follicular cell damage (13).

This study found a significant positive correlation between serum levels of TSH and inflammatory markers in hypothyroid patients. Gupta G et al., also reported a significant increase in IL-6 levels in subclinical hypothyroid patients than in healthy euthyroid controls and was positively correlated with serum TSH levels (6). Davies PH et al., found a significant negative correlation between serum total T3 and IL-6 and total T4 and IL-6 (24). Thyroid-stimulating hormone stimulates the release of IL-6 in adipocytes (25). IL-6 has a key role in the early stages of inflammation and also plays a modulator in the course of atherogenesis. It helps in speeding up atherogenesis via producing C- reactive protein by liver (26). TNF-α is involved in systemic inflammation and also stimulates the acute phase reaction. It is also an important stimulus for IL-6 production (27). It acts at each level of the hypothalamic-pituitary-thyroid axis to produce various changes in the axis (28),(29). TNF-α receptors are present in thyroid follicular cells and are implicated in the cytotoxic mechanisms causing thyroid destruction in autoimmune thyroid disease (30).

Patients attained euthyroid status after levothyroxine therapy and there was a significant decrease in the IL-6 and TNF-α levels. These findings were supported by Tayde PS et al., IL-6 and TNF-α were significantly elevated in hypothyroid cases compared to healthy controls and after treatment with levothyroxine, all the markers were reduced significantly (31). Diez JJ et al., also reported a significantly higher level of TNF-α in patients with hypothyroidism but did not normalise after the normalisation of thyroid functions (30). Contrary to this, the present study group was newly diagnosed hypothyroid patients, who restored raised inflammatory markers after levothyroxine therapy, proving the role of early treatment in the resumption of normal levels of markers.

Limitation(s)

The inflammatory markers were not tested twice in the control group and the small sample size was the main limitation of this study. Further studies are required with more sample size and other inflammatory markers as well to highlight the mechanistic process of the disease.

Conclusion

It was found that the hypothyroid state is associated with raised inflammatory markers. Levothyroxine replacement therapy has a role in reversing the adverse situation of hypothyroidism by restoring raised inflammatory markers. This can be useful to the clinicians as the role of the early diagnosis and treatment on the restoration of raised inflammatory markers and chronic inflammation in newly diagnosed hypothyroid patients. Chronic inflammation seems to be associated with an increased risk of cardiovascular disease so treating the chronic inflammation with levothyroxine in hypothyroidism patients can be saved from the risk of cardiac diseases in turn.

References

1.
Montesinos MDM, Pellizas CG. Thyroid hormone action on innate immunity. Front Endocrinol (Lausanne). 2019;10:350. doi: 10.3389/fendo.2019.00350. [crossref] [PubMed]
2.
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-43. Doi: 10.1161/hc0902.104353. [crossref] [PubMed]
3.
Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103(13):1813-18. Doi: 10.1161/01.cir.103.13.1813. [crossref] [PubMed]
4.
Surks MI, Ocampo E. Subclinical thyroid disease. Am J Med. 1996;100(2):217-23. Doi: 10.1016/s0002-9343(97)89462-4. [crossref]
5.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34. Doi: 10.1001/archinte.160.4.526. [crossref] [PubMed]
6.
Gupta G, Sharma P, Kumar P, Itagappa M. Study on subclinical hypothyroidism and its association with various inflammatory markers. J Clin Diagn Res. 2015;9(11):BC04-06. Doi: 10.7860/JCDR/2015/14640.6806. [crossref] [PubMed]
7.
Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. low-grade systemic inflammation causes endothelial dysfunction in patients with hashimato’s thyroiditis. J Clin Endocrinol Metab. 2006; 91(12):5076-82. [crossref] [PubMed]
8.
Turemen EE, Cetinarslan B, Sahin T, Canturk Z, Tarkun I. Endothelial dysfunction and low-grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011;58(5):349-54. [crossref] [PubMed]
9.
Kiziltunc A, Başoğlu M, Avci B, Capoğlu I. Serum Il-6 and TNF-α in patients with thyroid disorders. Turk J Med Sci. 1999;29:25-29.
10.
Lowe GD. Circulating inflammatory markers and risks of cardiovascular and noncardiovascular disease. J Thromb Haemost. 2005;3(8):1618-27. [crossref] [PubMed]
11.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO , Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-11. [crossref] [PubMed]
12.
Ridker PM. C-reactive protein: A simple test to help predict the risk of heart attack and stroke. Circulation. 2003;108(12):e81-85. [crossref]
13.
Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab. 1997;82(1):78-81. [crossref] [PubMed]
14.
Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020;95:304e7. [crossref] [PubMed]
15.
Hariyanto TI, Kurniawan A. Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1429-30. [crossref] [PubMed]
16.
Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: A retrospective study. Thyroid. 2021;31(1):08-11. doi: 10.1089/thy.2020.063. [crossref] [PubMed]
17.
Dabas A, Singh H, Goswami B, Kumar K, Dubey A, Jhamb U, et al. Thyroid dysfunction in COVID-19. Indian J Endocr Metab. 2021;25(3):198-201. [crossref] [PubMed]
18.
Goyal S, Dixit A, Vaney N, Madhu S. Cognitive status in hypothyroid patients before and after attainment of euthyroid state. Indian J Physiol Pharmacol. 2018;62:113-19.
19.
Goyal S, Dixit A, Vaney N, Madhu SV. Effect of hypothyroidism on cognitive status: Evidence from Stroop task. Indian J Med Spec 2020;11:34-39. [crossref]
20.
Vayá A, Gimenez C, Sarnago A, Alba A, Rubio O, Hernandez-Mijares A, et al. Subclinical hypothyroidism and cardiovascular risk. Clinical Hemorheology and Microcirculation. 2014;58(1):01-07. [crossref] [PubMed]
21.
Whiting A, Reyes JVM, Ahmad S, Lieber J. Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism. Cureus. 2021;13(5):e14815. Doi: 10.7759/cureus.14815. [crossref]
22.
Chen Y, Li X, Dai Y, Zhang J. The Association between COVID-19 and thyroxine levels: A meta-analysis. Front Endocrinol (Lausanne). 2022;12:779692. Doi: 10.3389/fendo.2021.779692. [crossref] [PubMed]
23.
Malik J, Malik A, Javaid M, Zahid T, Ishaq U, Shoaib M, et al. Thyroid function analysis in COVID-19: A retrospective study from a single center. PLoS One. 2021;16(3):e0249421. Doi: 10.1371/journal.pone.0249421. [crossref] [PubMed]
24.
Davies PH, Black EG, Sheppard MC, Franklyn JA. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol (Oxf). 1996;44(2):199-05. [crossref] [PubMed]
25.
Auntunes TT, Gagnon A, Bell A, Sorisky A. thyroid stimulating hormone stimulates interleukin 6 release from 3T3-L1 adipocytes through a cAMP protein kinase A pathway. Obes Res. 2005;13(12):2066-71. [crossref] [PubMed]
26.
Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-74. [crossref] [PubMed]
27.
Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989;142(1):144-47.
28.
Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 1986;320(6063):584-88. [crossref] [PubMed]
29.
Pang XP, Hershman JM, Mirell CJ, Pekary AE. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology. 1989;125(1):76-84. [crossref] [PubMed]
30.
Díez JJ, Hernanz A, Medina S, Bayón C, Iglesias P. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol (Oxf). 2002;57(4):515-21. [crossref] [PubMed]
31.
Tayde PS, Bhagwat NM, Sharma P, Sharma B, Dalwadi PP, Sonawane A, et al. Hypothyroidism and depression: Are cytokines the link? Indian J Endocrinol Metab. 2017;21(6):886-92. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/56898.16940

Date of Submission: Apr 06, 2022
Date of Peer Review: May 13, 2022
Date of Acceptance: Jul 09, 2022
Date of Publishing: Sep 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 13, 2022
• Manual Googling: Jul 07, 2022
• iThenticate Software: Aug 26, 2022 (17%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com